Skip to main content
Focus

Mediator: the scandal that's rocked the drug world

The Mediator affair continues to haunt France's second largest pharmaceutical, Servier. New revelations allege that the company falsified documents to get the pill marketed as a diabetic drug although they were aware of its appetite-suppressant qualities. Mediator was pulled off the shelves in 2009 by French health authorities amid concerns that it had fatal side-effects. We take a closer look at the latest developments.

Page not found

The content you requested does not exist or is not available anymore.